Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Hill-Rom Holdings, Inc. provides medical technologies and services primarily related to beds for the healthcare industry worldwide. The company was founded in 1969 and has a market cap of $2.14 billion.
With healthcare demand continuing to grow on the back of an aging domestic population, Hill-Rom was able to deliver exceptional Q2 results on July 28 that handily beat expectations.
Second-Quarter Results
Revenue for the period was up 8% from last year to $361 million. Earnings also came in strong at 45 cents, 45% ahead of the Zacks Consensus Estimate, pushing the company's average earnings surprise over the last four quarters to 28%.
Hill-Rom's strong performance was driven by its North American Acute Care division, where sales were up 8% to $205 million.
Although the company's International and Surgical division produces a smaller portion of its revenue, sales in the group were up 15% from last year in constant currency to $11 million on strength out of Europe, the Middle East and Asia.
Margin Expansion
Hill Rom was able to compliment its solid top-line growth by boosting its margins, with gross margin up 440 basis points from last year to 49.4%. Its adjusted operating margin came in at 13.2%, up from 7.4% last year.
Balance Sheet
Hill Rom continues to remain focused on strengthening its balance sheet, with cash and equivalents up $68 million from last year to $196 million. Its debt is shrinking too, down $44 million from last year to $154 million.
Estimates
Estimates took a really nice jump on the good quarter, with the current year up 24 cents to $1.63. The next-year estimate added 21 cents to $1.84, a solid 12% growth projection.
Valuation
The valuation picture looks really solid here too, with a forward P/E of 20.5X against its peers 19X.
2-Year Chart
HRC took a big jump higher on the good quarter, hitting a new all-time high at $35.89. Look for support from the trend line on any weakness, take a look below.
Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the new Zacks Momentum Trader Service.
Read the full reports :
Snapshot Report on HRC